[144] Nuvation Bio Inc. SEC Filing
NUVB filed a Form 144 notice for a proposed sale of its Class A common stock. The filing covers a planned sale of 15,000 Class A common shares on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $71,475. These 15,000 shares were acquired on 11/17/2025 by exercising stock options under a registered plan, paid for in cash on the same date. The filing notes that 342,833,433 shares of Class A common stock were outstanding, providing context for the size of the planned sale.
- None.
- None.
FAQ
What does NUVB's latest Form 144 filing disclose?
The Form 144 for NUVB discloses a planned sale of 15,000 shares of Class A common stock on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $71,475.
How many NUVB shares are planned to be sold under this Form 144?
The notice covers the proposed sale of 15,000 Class A common shares of NUVB, with an aggregate market value of $71,475.
How and when were the NUVB shares in the Form 144 acquired?
The 15,000 NUVB Class A common shares were acquired on 11/17/2025 through the exercise of stock options under a registered plan, and were paid for in cash on the same date.
Which broker will handle the NUVB Form 144 share sale?
The planned sale of NUVB Class A common stock will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.
On which exchange will the NUVB shares in this Form 144 be sold?
The Form 144 indicates that the 15,000 Class A common shares of NUVB are expected to be sold on the NYSE.
How many NUVB shares were outstanding in relation to this Form 144 sale?
The filing states that there were 342,833,433 shares of NUVB Class A common stock outstanding, which provides context for the 15,000-share planned sale.